UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029181
Receipt number R000033362
Scientific Title Effect of Pike oil in healthy subjects as phase II and III study
Date of disclosure of the study information 2017/09/18
Last modified on 2020/09/18 14:35:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Pike oil in healthy subjects as phase II and III study

Acronym

Phase II/III study for pike oil benefits

Scientific Title

Effect of Pike oil in healthy subjects as phase II and III study

Scientific Title:Acronym

Phase II/III study for pike oil benefits

Region

Japan


Condition

Condition

Adults Healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the benefit of pike oil in healthy subjects

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement of FMD levels

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

4 weeks intake of pike oil

Interventions/Control_2

4 weeks intake of placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

<=20,<60 years healthy subjects

Key exclusion criteria

patients who diagnosed/treated lipid abnormal or any disease

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Sakaue

Organization

Tokushima University

Division name

Nutrition and Metabolism

Zip code

7708503

Address

3-18-15 Kumamoto, Tokushima

TEL

088-633-9249

Email

hsakaue@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Rie
Middle name
Last name Tsutsumi

Organization

Tokushima University

Division name

Nutrition and Metabolism

Zip code

7708503

Address

3-18-15 Kuramoto, Tokushima

TEL

088-633-9249

Homepage URL


Email

rtsutsumi@tokushima-u.ac.jp


Sponsor or person

Institute

Tokushima University hospital

Institute

Department

Personal name



Funding Source

Organization

JSPS

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokushima University Hospital

Address

2-50-1 Kuramoto Tokushima

Tel

81-88-633-9294

Email

awachiken@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

徳島大学


Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 30 Day

Date of IRB

2017 Year 09 Month 27 Day

Anticipated trial start date

2017 Year 10 Month 01 Day

Last follow-up date

2018 Year 01 Month 31 Day

Date of closure to data entry

2018 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 08 Month 31 Day

Date analysis concluded

2019 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 09 Month 18 Day

Last modified on

2020 Year 09 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033362


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name